BioSpace News Archive

Campaign offers a chance to attend a private, virtual performance by GRAMMY®Award-winning artist and breast cancer survivor Sheryl Crow [20-August-2020] MARLBOROUGH, Mass. , Aug. 20, 2020 /PRNewswire/ -- WHAT: At the start of the COVID-19 pandemic, many health officials, professional societies and patient a

August Bioservices, an emerging leader amongst contract development and manufacturing organizations (“CDMOs”) providing drug discovery, development, and manufacturing services, today revealed its new brand identity.

Respiratory Motion Inc. (RMI) today announced that C. Raymond Larkin Jr. will act as a Strategic Advisor to the Company.

Vioguard, Inc., the industry leader in ultraviolet light disinfecting solutions, today announced Brian Mitchell has joined the company as Vice President of Sales. His role will support the need for Viogu

Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has awarded an orphan products clinical trial grant to support the ongoing phase 3 study of emixustat in Stargardt disease (Clinicaltrials.gov identifier: NCT0

Temporary Urgent Public Health Need Site also authorized in Toronto shelter to help reduce overdoses during COVID-19

Conversion Labs, Inc., a direct-to-consumer telemedicine and wellness company, has been invited to present at LD Micro 500 virtual institutional investor conference being held on September 1-4, 2020.

MaaT Pharma announced today it plans to initiate a new collection and manufacturing campaign to be completed in the second half of 2020 for the production of its microbiome biotherapeutics, enema formulation MaaT013 and capsule formulation MaaT033.

Recognizing the need for technologies to help advance the response and recovery to the COVID-19 pandemic, KPMG LLP has built the technology architecture for a solution that can match patients in clinical trials for convalescent plasma therapy to recovered patients willing to donate their antibodies.

Bayer announced today that it has reached agreements with plaintiff law firms to resolve approximately 90% of the nearly 39,000 total filed and unfiled U.S. Essure™ claims involving women who allege device-related injuries